The A’s made their final round of roster moves on Saturday night, optioning lefty Pedro Figueroa and infielder Andy Parrino to Triple-A Sacramento and placing new shortstop Hiroyuki Nakajima on the 15-day disabled list with a strained left hamstring.
Nakajima suffered the strain Tuesday in the 10th inning of a Cactus League game against the Indians. He wound up batting .167/.286/.190 with one extra-base hit (a double) in 49 spring plate appearances.
The A’s will use Jed Lowrie as their primary shortstop in the early going this season.
Nakajima, 30, signed a two-year, $6.5 million free agent contract with Oakland in December.
MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.
Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”
Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.
Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.